The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy
Open accessAbstract
BACKGROUND: Idiopathic membranous nephropathy is an autoimmune disease. In approximately 70% of patients, it is associated with autoantibodies against the phospholipase A2 receptor 1 (PLA2R1). Antigenic targets in the remaining patients are unknown. METHODS: Using Western blotting, we screened serum samples from patients with idiopathic membranous nephropathy, patients with other glomerular diseases, and healthy controls for antibodies against human native glomerular proteins. We partially purified a putative new antigen, identified this protein by means of mass spectrometry of digested peptides, and validated the results by analysis of recombinant protein expression, immunoprecipitation, and immunohistochemical analysis. RESULTS: Serum samples from 6 of 44 patients in a European cohort and 9 of 110 patients in a Boston cohort with anti-PLA2R1-negative idiopathic membranous nephropathy recognized a glomerular protein that was 250 kD in size. None of the serum samples from the 74 patients with idiopathic membranous nephropathy who were seropositive for anti-PLA2R1 antibodies, from the 76 patients with other glomerular diseases, and from the 44 healthy controls reacted against this antigen. Although this newly identified antigen is clearly different from PLA2R1, it shares some biochemical features, such as N-glycosylation, membranous location, and reactivity with serum only under nonreducing conditions. Mass spectrometry identified this antigen as thrombospondin type-1 domain-containing 7A (THSD7A). All reactive serum samples recognized recombinant THSD7A and immunoprecipitated THSD7A from glomerular lysates. Moreover, immunohistochemical analyses of biopsy samples from patients revealed localization of THSD7A to podocytes, and IgG eluted from one of these samples was specific for THSD7A. CONCLUSIONS: In our cohort, 15 of 154 patients with idiopathic membranous nephropathy had circulating autoantibodies to THSD7A but not to PLA2R1, a finding that suggests a distinct subgroup of patients with this condition. (Funded by the French National Center for Scientific Research and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
M-Type Phospholipase A 2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy
Beck, L. H., Bonegio, R. G. B., Lambeau, G., Beck, D. M., Powell, D. W., Cummins, T. D., Klein, J. B., & Salant, D. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810457 · Cited by 2,347
Self-citationHoch, W., McConville, J., Helms, S., Newsom-Davis, J., Melms, A., & Vincent, A. (2001) · Nature Medicine · doi:10.1038/85520 · Cited by 1,183
East, L. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00319-7 · Cited by 621
Antenatal Membranous Glomerulonephritis Due to Anti–Neutral Endopeptidase Antibodies
Debiec, H., Guigonis, V., Mougenot, B., Decobert, F., Haymann, J.-P., Bensman, A., Deschênes, G., & Ronco, P. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012895 · Cited by 528
Risk HLA-DQA1 and PLA 2 R1 Alleles in Idiopathic Membranous Nephropathy
Stanescu, H. C., Arcos-Burgos, M., Medlar, A., Bockenhauer, D., Kottgen, A., Dragomirescu, L., Voinescu, C., Patel, N., Pearce, K., Hubank, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009742 · Cited by 523
Hoxha, E., Thiele, I., Zahner, G., Panzer, U., Harendza, S., & Stahl, R. A. K. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013040430 · Cited by 353
Self-citationAntiphospholipase A2 Receptor Antibody Titer and Subclass in Idiopathic Membranous Nephropathy
Hofstra, J. M., Debiec, H., Short, C. D., Pellé, T., Kleta, R., Mathieson, P. W., Ronco, P., Brenchley, P. E., & Wetzels, J. F. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012030242 · Cited by 321
Hoxha, E., Kneissler, U., Stege, G., Zahner, G., Thiele, I., Panzer, U., Harendza, S., Helmchen, U. M., & Stahl, R. A. K. (2012) · Kidney International · doi:10.1038/ki.2012.209 · Cited by 272
Self-citationDefining cell-type specificity at the transcriptional level in human disease
Ju, W., Greene, C. S., Eichinger, F., Nair, V., Hodgin, J. B., Bitzer, M., Lee, Y.-S., Zhu, Q., Kehata, M., Li, M., et al. (2013) · Genome Research · doi:10.1101/gr.155697.113 · Cited by 252
Larsen, C. P., Messias, N. C., Silva, F. G., Messias, E., & Walker, P. D. (2013) · Modern Pathology · doi:10.1038/modpathol.2012.207 · Cited by 248
Cited by
Primary Membranous Nephropathy
Couser, W. G. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11761116 · Cited by 690
Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up
Dahan, K., Debiec, H., Plaisier, E., Cachanado, M., Rousseau, A., Wakselman, L., Michel, P.-A., Mihout, F., Dussol, B., Matignon, M., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016040449 · Cited by 439
A Proposal for a Serology-Based Approach to Membranous Nephropathy
De Vriese, A. S., Glassock, R. J., Nath, K. A., Sethi, S., & Fervenza, F. C. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016070776 · Cited by 372
Pathophysiological advances in membranous nephropathy: time for a shift in patient's care
Ronco, P., & Debiec, H. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60731-0 · Cited by 369
Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy
Sethi, S., Debiec, H., Madden, B., Charlesworth, M. C., Morelle, J., Gross, L., Ravindran, A., Buob, D., Jadoul, M., Fervenza, F. C., et al. (2020) · Kidney International · doi:10.1016/j.kint.2019.09.014 · Cited by 360
Floege, J., & Amann, K. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00272-5 · Cited by 306
Autoantibodies Targeting Nephrin in Podocytopathies
Hengel, F. E., Dehde, S., Lassé, M., Zahner, G., Seifert, L., Schnarre, A., Kretz, O., Demir, F., Pinnschmidt, H. O., Grahammer, F., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2314471 · Cited by 280
Self-citationFloege, J., Barbour, S. J., Cattran, D. C., Hogan, J. J., Nachman, P. H., Tang, S. C. W., Wetzels, J. F. M., Cheung, M., Wheeler, D. C., Winkelmayer, W. C., et al. (2019) · Kidney International · doi:10.1016/j.kint.2018.10.018 · Cited by 263
Self-citationAngeletti, A., Migliorini, P., Bruschi, M., Pratesi, F., Candiano, G., Prunotto, M., Verrina, E., & Ghiggeri, G. M. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102977 · Cited by 18
Metadata
- Authors
- Tomas, N. M., Beck, L. H., Meyer-Schwesinger, C., Seitz-Polski, B., Ma, H., Zahner, G., Dolla, G., Hoxha, E., Helmchen, U., Dabert-Gay, A.-S., Debayle, D., Merchant, M., Klein, J., Salant, D. J., Stahl, R. A. K., & Lambeau, G.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-12-11
- Volume
- 371
- Issue
- 24
- Pages
- 2277-2287
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2083760961
- Cited by
- 945
- References
- 12
- FWCI
- 42.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.